The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment	Hormone Refractory Prostate Cancer	Active, not recruiting	Phase 2	2026-02-04		NCT02955082

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Barts & The London NHS Trust	60
Buckinghamshire Healthcare NHS Trust	7
Dartford and Gravesham NHS Foundation Trust	2
East and North Hertfordshire NHS Trust	19
European Research Council	11
Imperial College Healthcare NHS Trust	49
Institute of Cancer Research, United Kingdom	59
Maidstone & Tunbridge Wells NHS Trust	5
Northampton General Hospital NHS Trust	4
Nottingham University Hospitals NHS Trust	53
Royal Free Hampstead NHS Trust	1
Royal Marsden NHS Foundation Trust	89
Yeovil District Hospital NHS Foundation Trust	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institute of Cancer Research and Royal Marsden Hospital	Sutton	United Kingdom	6